mr 2034 has been researched along with buprenorphine in 2 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (buprenorphine) | Trials (buprenorphine) | Recent Studies (post-2010) (buprenorphine) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 7,273 | 1,223 | 3,826 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chahl, LA | 1 |
| Gmerek, DE; Woods, JH | 1 |
2 other study(ies) available for mr 2034 and buprenorphine
| Article | Year |
|---|---|
Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.
Topics: Animals; Benzomorphans; Buprenorphine; Cyclazocine; Endorphins; Ethylketocyclazocine; Female; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle, Smooth; Naloxone; Narcotics; Substance P; Substance Withdrawal Syndrome | 1986 |
Substitution and primary dependence studies in animals.
Topics: Animals; Behavior, Animal; Benzomorphans; Buprenorphine; Butorphanol; Codeine; Discrimination, Psychological; Humans; Macaca mulatta; Morphinans; Morphine; Morphine Dependence; Nalbuphine; Narcotic Antagonists; Pentazocine; Piperidines; Substance Withdrawal Syndrome | 1985 |